搜索结果: 1-6 共查到“传染病学 antibody”相关记录6条 . 查询时间(0.5 秒)
A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
Preventive medicine SARS-CoV-2 Viral infection
2020/6/11
An outbreak of the coronavirus disease 2019 (COVID-19)1–3, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)4 spread globally. Countermeasures are needed to treat and prevent ...
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
2019-nCoV SARS-CoV ACE2 monoclonal antibody RBD
2020/6/12
The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, how...
Levels of Haemophilus influenzae type B (Hib) antibody in Turkey before routine immunization
Haemophilus influenzae type b antibody serosurveillance
2010/11/22
The Haemophilus influenzae type b (Hib) vaccine was introduced into the routine immunization schedule in Turkey on January 1, 2007. This study investigates the immunity to Hib prior to the introductio...
New antibody development brings treatment for amyloidosis a step closer
New antibody development treatment amyloidosis
2010/10/25
Scientists funded by the Medical Research Council (MRC) have devised a new approach to treat amyloidosis, according to new research published today. Systemic amyloidosis is a serious and usually fatal...
Neutropenia in Patients with Primary Antibody Deficiency Disorders
Neutropenia Immunologic Deficiency Syndromes Infection Iran
2010/2/8
Neutropenia is characterized by decrease in the absolute number of circulating neutrophils and an increase susceptibility to infections. The current study was performed in order to explain the clinica...
Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update
anti-IgE therapy asthma immunotherapy omalizumab seasonal allergic rhinitis
2010/11/17
Seasonal allergic rhinitis (SAR) induced by Japanese cedar pollens is a substantial problem in Japan. Omalizumab, a novel humanized monoclonal anti-immunoglobulin E (IgE) antibody, has already been pr...